Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up BRLT Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain COST Q1 2026 Earnings EPS Falls Short of Consensus Stock Dips 22 PUK Q4 2025 Earnings EPS Misses Estimates by 2917 Stock Declines Allstate Q1 2026 Earnings EPS Soars Past Estimates by 447 Driven by Strong Underwriting SNYR Q1 2026 Earnings Significant EPS Miss Amid Lack of Revenue Disclosure